Omangay, Loreto P.

HRN: 28-71-34  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/20/2026
03/26/2026
IV
2.25gm
Q6
Septicemia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: